Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Neutral

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

CNS Pharmaceuticals, Inc. Common Stock (CNSP)

Pharmaceutical Preparations

https://www.cnspharma.com

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma.

2100 WEST LOOP SOUTH, SUITE 900
HOUSTON, TX

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/08/2019

Market Cap

381,480

Shares Outstanding

6,220,000

Weighted SO

6,214,598

Total Employees

N/A

Upcoming Earnings

N/A

Beta

1.0790

Last Div

0.0000

Range

0.125-137.5

Chg

-0.0080

Avg Vol

4870362

Mkt Cap

381480

Exch

NASDAQ

Country

US

Phone

800 946 9185

DCF Diff

-2.1603

DCF

3.2903

Div Yield

0.0000

P/S

59.9623

EV Multiple

0.0618

P/FV

-0.0117

Div Yield %

0.0000

P/E

-0.0031

PEG

0.0000

Payout

0.0000

Current Ratio

0.3172

Quick Ratio

0.3172

Cash Ratio

0.2206

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

0.5803

Op Margin

-2512.7625

Pretax Margin

-2510.7743

Net Margin

-2510.7743

Eff Tax Rate

-0.0008

ROA

-6.4689

ROE

4.2891

ROCE

3.7233

NI/EBT

1.0000

EBT/EBIT

0.9992

EBIT/Rev

-2512.7625

Debt Ratio

0.0499

D/E

-0.0287

LT Debt/Cap

0.0000

Total Debt/Cap

-0.0296

Int Coverage

-2323.2372

CF/Debt

-101.4823

Equity Multi

-0.5751

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

1.7906

Asset Turnover

0.0026

OCF/Share

-33.2078

FCF/Share

-33.2182

Cash/Share

3.9601

OCF/Sales

-1965.9692

FCF/OCF

1.0003

CF Coverage

-101.4823

ST Coverage

-101.4823

CapEx Coverage

-3206.2281

Div&CapEx Cov

-3206.2281

P/BV

-0.0117

P/B

-0.0117

P/S

59.9623

P/E

-0.0031

P/FCF

-0.0305

P/OCF

-0.0040

P/CF

-0.0040

PEG

0.0000

P/S

59.9623

EV Multiple

0.0618

P/FV

-0.0117

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation